X-ray lightsource at DESY identifies promising candidates for COVID drugs
Electron density map of the most antiviral active ingredient calpeptin (yellow) binding at the main protease. © DESY/Sebastian Günther
At DESY's high-brilliance X-ray light source PETRA III, a team from more than 30 research institutions has identified several candidates for active substances against the coronavirus SARS-CoV-2. They bind to an important protein of the virus and could thus be the basis for a drug against Covid-19. The MX team from HZB examined part of the measurement data with special analysis algorithms in order to identify suitable active substances. The study has now been published in the renowned journal Science.
In a so-called X-ray screening, the researchers, under the leadership of DESY, tested almost 6000 known active substances that already exist for the treatment of other diseases in a short amount of time. After measuring about 7000 samples, the team was able to identify a total of 37 substances that bind to the main protease (Mpro) of the SARS-CoV-2 virus, as the scientists report online today in the journal Science. Seven of these substances inhibit the activity of the protein and thus slow down the multiplication of the virus. Two of them do this so promisingly that they are currently under further investigation in preclinical studies. This drug screening – probably the largest of its kind – also revealed a new binding site on the main protease of the virus to which drugs can couple.
“The active substances Calpeptin and Pelitinib clearly showed the highest antivirality with good cell compatibility. Our cooperation partners have therefore already started preclinical investigations with these two substances,” explains DESY researcher Sebastian Günther, first author of the Science publication.
In addition to DESY scientists, researchers from the Universities of Hamburg and Lübeck, the Bernhard Nocht Institute for Tropical Medicine, the Fraunhofer Institute for Translational Medicine and Pharmacology, the Heinrich Pette Institute, the European XFEL, the European Molecular Biology Laboratory EMBL, the Max Planck Society, the Helmholtz-Zentrum Berlin and other institutions are involved in the work.
Note: This is a shortened version of the full text of the press release published at DESY Website.
DESY/red.
https://www.helmholtz-berlin.de/pubbin/news_seite?nid=22664;sprache=en
- Copy link
-
The future of corals – what X-rays can tell us
This summer, it was all over the media. Driven by the climate crisis, the oceans have now also passed a critical point, the absorption of CO
2 is making the oceans increasingly acidic. The shells of certain sea snails are already showing the first signs of damage. But also the skeleton structures of coral reefs are deteriorating in more acidic conditions. This is especially concerning given that corals are already suffering from marine heatwaves and pollution, which are leading to bleaching and finally to the death of entire reefs worldwide. But how exactly does ocean acidification affect reef structures?
Prof. Dr. Tali Mass, a marine biologist from the University of Haifa, Israel, is an expert on stony corals. Together with Prof. Dr. Paul Zaslansky, X-ray imaging expert from Charité Berlin, she investigated at BESSY II the skeleton formation in baby corals, raised under different pH conditions. Antonia Rötger spoke online with the two experts about the results of their recent study and the future of coral reefs.
-
Susanne Nies appointed to EU advisory group on Green Deal
Dr. Susanne Nies heads the Green Deal Ukraina project at HZB, which aims to support the development of a sustainable energy system in Ukraine. The energy expert has now also been appointed to the European Commission's scientific advisory group to comment on regulatory burdens in connection with the net-zero target (DG GROW).
-
Long-term stability for perovskite solar cells: a big step forward
Perovskite solar cells are inexpensive to produce and generate a high amount of electric power per surface area. However, they are not yet stable enough, losing efficiency more rapidly than the silicon market standard. Now, an international team led by Prof. Dr. Antonio Abate has dramatically increased their stability by applying a novel coating to the interface between the surface of the perovskite and the top contact layer. This has even boosted efficiency to almost 27%, which represents the state-of-the-art. After 1,200 hours of continuous operation under standard illumination, no decrease in efficiency was observed. The study involved research teams from China, Italy, Switzerland and Germany and has been published in Nature Photonics.